Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000891092-14-006033
Filing Date
2014-08-11
Accepted
2014-08-11 12:43:01
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G e60009sc13g.txt SC 13G 24404
  Complete submission text file 0000891092-14-006033.txt   26342
Mailing Address 152 WEST 57TH STREET 33RD FLOOR NEW YORK NY 10019
Business Address 152 WEST 57TH STREET 33RD FLOOR NEW YORK NY 10019 212-370-0303
SCOPIA CAPITAL MANAGEMENT LLC (Filed by) CIK: 0001279150 (see all company filings)

EIN.: 300711986 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 101 MAIN STREET SUITE 1850 CAMBRIDGE MA 02142
Business Address 101 MAIN STREET SUITE 1850 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Subject) CIK: 0001338042 (see all company filings)

EIN.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-85739 | Film No.: 141029695
SIC: 2834 Pharmaceutical Preparations